Open AccessPredictors of proteinuria reduction by monotherapy with an angiotensin receptor blocker, olmesartan
Author(s) -
Minamo Ono,
Michio Fukuda,
Toshiyuki Miura,
Masashi Mizuno,
Yoko Kato,
Ryo Sato,
Takehiro Naito,
Hiroyuki Togawa,
Yuji Sasakawa,
Tatsuya Tomonari,
Tadashi Ichikawa,
Yuichi Shirasawa,
Akinori Ito,
Atsuhiro Yoshida,
Genjiro Kimura
Publication year - 2012
Publication title -
journal of the renin-angiotensin-aldosterone system
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 46
eISSN - 1752-8976
pISSN - 1470-3203
DOI - 10.1177/1470320311434817
Subject(s) - olmesartan , albuminuria , proteinuria , renal function , medicine , urology , endocrinology , blood pressure , angiotensin receptor , angiotensin ii , kidney
It is known that reduced glomerular filtration rate (GFR) is a crucial factor to limit the blood pressure lowering effect of antihypertensives. In the present study, we tested whether the effects of monotherapy with an angiotensin receptor blocker (ARB) to lower proteinuria could be restricted by reduced GFR.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom